The KCNH voltage-dependent potassium channels (ether-à-go-go, EAG; EAG-related gene, ERG; EAG-like channels, ELK) are important regulators of cellular excitability 1-3 and have key roles in diseases such as cardiac long QT syndrome type 2 (LQT2) 4 , epilepsy 5 , schizophrenia 6 and cancer 7 . The intracellular domains of KCNH channels are structurally distinct from other voltage-gated channels. The amino-terminal region contains an eag domain, which is composed of a Per-Arnt-Sim (PAS) domain and a PAS-cap domain 8 , whereas the carboxy-terminal region contains a cyclic nucleotidebinding homology domain (CNBHD), which is connected to the pore through a C-linker domain. Many disease-causing mutations localize to these specialized intracellular domains, which underlie the unique gating and regulation of KCNH channels 9 . It has been suggested that the eag domain may regulate the channel by interacting with either the S4-S5 linker or the CNBHD 8,10 . Here we present a 2 Å resolution crystal structure of the eag domain-CNBHD complex of the mouse EAG1 (also known as KCNH1) channel. It displays extensive interactions between the eag domain and the CNBHD, indicating that the regulatory mechanism of the eag domain primarily involves the CNBHD. Notably, the structure reveals that a number of LQT2 mutations at homologous positions in human ERG, in addition to cancer-associated mutations in EAG channels, localize to the eag domain-CNBHD interface. Furthermore, mutations at the interface produced marked effects on channel gating, demonstrating the important physiological role of the eag domain-CNBHD interaction. Our structure of the eag domain-CNBHD complex of mouse EAG1 provides unique insights into the physiological and pathophysiological mechanisms of KCNH channels.
nucleotide-binding domains of cyclic nucleotide-gated (CNG) and hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels 11, 12 . The CNBHD of KCNH channels, however, does not bind cyclic nucleotides and regulates KCNH channel gating in a cyclic nucleotide-independent manner 13 . The N-terminal region contains an eag domain, not present in CNG and HCN channels, that also has a key role in channel gating. Composed of a 110-amino-acid PAS domain preceded by a highly conserved 25-amino-acid PAS-cap ( Fig. 1a and Supplementary Fig. 1 ), the eag domain regulates activation and inactivation in EAG1, and deactivation in human (h)ERG1 (also known as KCNH2) channels 9, 14 . Moreover, many of the human mutations that cause LQT2 and cancer localize to the conserved eag domain [15] [16] [17] . In addition, high expression of a primate-specific isoform of ERG (KCNH2-3.1), missing most of the eag domain, was shown to correlate with risk for schizophrenia 6 . The mechanism underlying KCNH channel regulation by the eag domain remains unclear. Two competing hypotheses have emerged. Some evidence suggests that the eag domain interacts with the S4-S5 linker and directly regulates the movement of the S4 voltage sensor 10, 18 . By contrast, other evidence favours the CNBHD as the interaction partner of the eag domain 9, 14, 19 . Using fluorescence anisotropy we found that the eag domain interacts directly with the CNBHD with an affinity of 13.2 6 2.3 mM ( Supplementary Fig. 2 ).
To uncover the mechanism for how the eag domain regulates the channel, we solved the X-ray crystal structure of the eag domain-CNBHD complex to 2.0 Å resolution ( Supplementary Table 1 ). There were eight chains in the asymmetric unit: four eag domains and four CNBHDs. The spatial arrangement of the eag domains and CNBHDs within the asymmetric unit showed three different eag domain-CNBHD interactions, here termed interactions A, B and C ( Supplementary Fig. 3 ). Interaction A, however, had considerably greater buried surface area than the other interactions ( Supplementary Table 2 ) and was confirmed 1 Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, Washington 98195, USA. by mutagenesis experiments in the intact channel (see below). Therefore interaction A was designated as the biological unit. Figure 1b shows the structure of the eag domain-CNBHD complex in the biological unit. The structure of the CNBHD (residues 552-720) includes the last 35 amino acids of the C-linker, the CNBHD, and 22 amino acids of the post-CNBHD region ( Fig. 1b and Supplementary  Fig. 1 ). The structure of the eag domain (residues 16-136) includes the PAS domain and the last 10 amino acids of the PAS-cap domain. These structures share many similarities to structures of CNBHD and eag domains crystallized alone. The CNBHD is similar to the isolated structures of mouse (m)EAG1 (root mean squared deviation (r.m.s.d.) 5 0.53 Å ) 12 , mosquito ERG (r.m.s.d. 5 1.05 Å ) 20 and zebrafish ELK (r.m.s.d. 5 1.39 Å ) 11 . The PAS domain is similar to the isolated structures of mEAG1 (r.m.s.d. 5 0.32 Å ) 21 , hERG1 (r.m.s.d. 5 0.71 Å ) 8, 21 and fruitfly ELK (r.m.s.d. 5 0.62 Å ) 21 , and also to the solution nuclear magnetic resonance (NMR) structures of hERG1 (refs 19, 22) .
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The interface between the eag domain and CNBHD in the co-crystal structure, however, is entirely novel. When we mapped the positions of disease-causing mutations in KCNH channels onto the structure of the eag domain-CNBHD complex, an unexpected trend emerged: many LQT2 mutations (at homologous positions in hERG1) and cancerassociated mutations (in hEAG1) are located at the interface between the eag domain and CNBHD ( Fig. 1c and Supplementary Fig. 4 ). These mutations, which alter channel gating as well as trafficking to the membrane 9, 14 , result in prolongation of the cardiac action potential (in hERG1) and were documented in several primary cancer types (in hEAG1) 15 . For example, position N34 in the eag domain, which forms hydrogen bonds with V634 of the CNBHD, was shown to cause LQT2 (hERG1(N33T)). In addition, Y44 of the eag domain forms an interaction with I637 and G639 of the CNBHD. Y44H in hEAG1 is a mutation known to be correlated with large intestine carcinoma 15 , and a mutation at the equivalent position in hERG1 (Y43C) causes LQT2 (ref. 23) ( Fig. 1c ). G639 is homologous to hERG1(G800W), a position known to cause LQT2 (ref. 23 ). These observations suggest that perturbation of the interaction between the eag domain and the CNBHD underlies part of the pathophysiology of KCNH-related diseases. Moreover, the clustering of so many mutations at the eag domain-CNBHD interface is consistent with this interface found in the crystal representing the physiological architecture of KCNH channels.
The interface between the eag domain and the CNBHD is extensive, with an average buried solvent-accessible surface area of ,1,400 Å 2 (Supplementary Table 2 ). The interface consists of three sub-regions:
(1) the intrinsic ligand motif of the CNBHD interacts with the aB-helix in the PAS domain; (2) the bA and bB strands of the PAS domain interact with the post-CNBHD segment of the CNBHD; and (3) an amphipathic helix (aCAP) in the PAS-cap domain forms an interaction with the b-roll of the CNBHD (Fig. 1a, b ).
The direct interaction of the PAS domain (residues 57-61) with the intrinsic ligand motif of the CNBHD was particularly surprising ( Fig. 2a, b ). Previous structures of isolated CNBHD from mEAG1 (ref. 12) and zebrafish ELK 11 showed that a short loop (residues 697-701) following the aC helix occupies the space filled by cyclic nucleotides in canonical cyclic nucleotide-binding domains ( Supplementary Fig. 1 ). This short loop was therefore called the 'intrinsic ligand'. Mutations in this intrinsic ligand were shown to regulate channel activity, shifting the voltage dependence and kinetics of activation and deactivation. Interestingly, mutations in the eag domain of KCNH channels result in similar alterations 9, 14, 16 . The interaction between the eag domain and the intrinsic ligand, and the functional similarities between mutations in these domains, suggests that the intrinsic ligand motif may be a critical determinant of the regulation of KCNH channels by the eag domain.
Another surprising site of interaction of the eag domain is the post-CNBHD region (beginning at residue 702). This region, immediately Cterminal to the intrinsic ligand, has been shown to mediate the regulation LETTER RESEARCH of KCNH channel function by a variety of cellular signalling events, including phosphorylation, and interaction with kinases, integrins and Ca 21 -calmodulin [24] [25] [26] . The eag domain-CNBHD structure shows that the post-CNBHD region interacts with the bA-bB loop of the eag domain (Fig. 2a, c and Supplementary Fig. 1 ). The interaction between the eag domain and the post-CNBHD region suggests that KCNH channel regulation through the post-CNBHD region may involve its interaction interface with the eag domain.
The crystal contains two different conformations of the eag domain-CNBHD complex. The asymmetric unit is composed of four copies of the complex, related by a two-fold non-crystallographic symmetry (Fig. 2d ). This results in two pairs of the complex ('type I' and 'type II' complexes) that are in a similar conformation within each pair (average r.m.s.d. 5 0.16 Å ), but a different conformation and B-factor distribution between pairs (r.m.s.d. 5 0.96 Å ) ( Fig. 2d and Supplementary Fig. 5 ). Alignment of the two conformations reveals that the angle between the eag domain and the CNBHD differs by 5u and that the distance between the two domains differs by 1.8 Å (between D47 of the eag domain and E578 of the CNBHD) ( Fig. 2e and Supplementary Video 1) . In addition, the aP helix (residues 649-651; Supplementary Fig. 1 ) undergoes a substantial rearrangement between the two conformations, possibly due, at least in part, to variation in the local crystal contacts ( Fig. 2e and Supplementary Video 1). These two conformations, if present in the intact channel, suggest that the eag domain-CNBHD complex is not static and represent a possible rearrangement associated with the gating regulation of the channel by the eag domain.
To determine the functional role of the eag domain-CNBHD interaction, we mutated the interaction interface between the eag domain and the CNBHD in intact mEAG1 channels. The interface contains a salt bridge between R57 in the aB helix of the PAS domain and D642 in the b6 strand of the CNBHD ( Fig. 3a and Supplementary Fig. 4 ). This salt bridge is present in both conformations of the biological unit and is not present in the other eag domain-CNBHD interactions in the crystal. Notably, R57 and D642 are conserved throughout the KCNH family ( Supplementary Fig. 1) , and mutation of the R57-equivalent position in hERG1 (hERG1(R56Q)) causes LQT2 (ref. 16 ). mEAG1 channels with mutations in the salt bridge were expressed in Xenopus oocytes and their currents were recorded. Individually the eag domain R57D mutation and the CNBHD D642R mutation each produced a slowing of activation with voltage steps to 150 mV ( Supplementary  Fig. 6 ). This resulted primarily from a new slow component to the activation time course and produced a three-to fivefold delay of the time to 90% current amplitude when compared to wild-type channels (Fig. 3b ) (R57D, 225 6 42 ms; D642R, 340 6 25 ms; wild type, 71 6 15 ms; P , 0.01; n 5 9-10). No changes in other biophysical properties of the channels were noted ( Supplementary Table 3 ). Importantly, in the double charge reversal mutant, R57D 1 D642R, the time course of channel activation was similar to wild type (68 6 23 ms, P . 0.05, n 5 6), suggesting that the salt bridge was restored (Fig. 3b) . These results indicate that the R57-D642 salt bridge is present in the intact channel, consistent with interaction A being the biological unit. In addition, these results indicate that the eag domain regulates the activation of mEAG1 channels by interaction with the CNBHD.
A third important region of interaction with the CNBHD is with the PAS-cap domain. The PAS-cap domain constitutes the first 25 amino acids of the eag domain. This domain is highly conserved within the KCNH family ( Supplementary Fig. 1 ) and has been shown to be crucial for proper activation and inactivation gating in KCNH channels 9, 27 . Notably, our structure of the eag domain-CNBHD complex reveals that an amphipathic helix (aCAP) of the PAS-cap domain of mEAG1 interacts directly with the CNBHD (Fig. 4a) . The structure shows that aCAP is nestled between a hydrophobic patch of the PAS domain and the b4-b5 strands and b8-b9 loop of the CNBHD. The structure of the PAS-cap domain was previously assessed using NMR of isolated eag domain from hERG1 (refs 10, 19, 22) . Structural alignment reveals that the PAS-cap domain in our eag domain-CNBHD complex is in a very different orientation from the NMR structures (Fig. 4b) . The orientation, however, is very similar to recent X-ray crystallography structures of isolated eag domains from hERG1 and ELK 21 . We propose that the spatial organization of the PAS-cap domain within the eag domain-CNBHD complex recapitulates the native conformation of this domain in the intact channel, and that the PAS-cap domain exerts its functional effects through its interaction with the CNBHD.
Although the PAS-cap domain itself does not contain any known LQT2 mutations and only one cancer-associated mutation (hEAG1(E19D)), its surroundings are rich in pathological loci, including hERG1 LQT2 mutation E788D 28 (E627 in mEAG1) in the b4 strand of the CNBHD 9,15 . These mutations may alter the gating properties of the channel by destabilizing the PAS-cap domain interaction with the CNBHD. To test this hypothesis, we measured the currents from mEAG1 channels mutated in the PAS-cap domain (R7A-R8A and R7E-R8E) and in the CNBHD region where the PAS-cap is bound (E627A and E627R). These positions are highly conserved within the KCNH family (Supplementary Fig. 1 ). The voltage dependence of activation of the PAScap mutations R7A-R8A and R7E-R8E were significantly shifted to more depolarized potentials, compared to wild-type channels ( Fig. 4c and Supplementary Table 4 ). The CNBHD mutations also showed a robust depolarizing shift, similar to that of the R7E-R8E mutant ( Fig. 4c 
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and Supplementary Table 4 ). Together, these results suggest that the interaction between the PAS-cap domain and the CNBHD regulates KCNH channel gating.
To model the orientation of the eag domain-CNBHD complex in the context of a four-fold symmetrical ion channel, we aligned the CNBHD of the complex with the homologous C-linker/CNBD of the mHCN2 channel (PDB code 1Q5O), which shares 35% sequence similarity with the CNBHD of mEAG1 ( Supplementary Fig. 1 ). The Clinker/CNBD in the mHCN2 structure assembles as a tetramer with a four-fold axis of rotational symmetry, in which the C-linker domains form most of the inter-subunit interactions 29 . Although our structure of the mEAG1 CNBHD lacks most of C-linker, the alignment resulted in a concentric arrangement of the eag domain-CNBHD complex, where the eag domains are positioned at the periphery of the C-linker/ CNBHD tetramer (Fig. 4d) . The post-CNBHD region points away from the centre and may be accessible for interaction with other proteins, such as kinases and Ca 21 -calmodulin, thought to regulate KCNH channels through sites in the post-CNBHD 26 . Mutagenesis studies in hERG1 channels suggest that this arrangement may exhibit domain swapping in which the eag domain of one subunit interacts with the CNBHD of a neighbouring subunit 9 .
The eag domain and the CNBHD have been shown to be important regulatory domains of the KCNH channel family. Mutations found in these regions lead to LQT2 and are associated with cancer. The structure of the eag domain-CNBHD complex of mEAG1 demonstrates that the interaction interface between the two domains serves as a hotspot for many of these mutations and provides a framework to better understand the mechanisms of gating and regulation of KCNH channels. Furthermore, understanding the molecular interactions within the KCNH channel complex, and their disruption in disease, may enable design of novel therapies for these devastating conditions.
METHODS SUMMARY
The mouse EAG1 eag domain (residues 6-136) and CNBHD (residues 552-724) were subcloned into a pETM11 vector containing an N-terminal hexa-histidine affinity tag followed by a tobacco etch virus (TEV) cleavage site. The proteins were expressed in BL21(DE3) Escherichia coli cells as described previously 11 , purified on a Ni 21 affinity column and then on an ion-exchange (CNBHD) or size-exclusion (eag domain) column, following an overnight cleavage with TEV at 4 uC. The proteins were concentrated to about 475 mM, flash-frozen and stored at 280 uC until use. The eag domain and the CNBHD were mixed in a 1:1 molar ratio before experimentation. Crystals were grown at 20 uC using sitting-drop vapour diffusion by mixing a 2:1 (v/v) ratio of protein mixture and a reservoir solution containing 18% (w/v) PEG 3350, 1.8% (v/v) tacsimate, 10 mM MnCl 2 and 90 mM HEPES, pH 7.5. The crystals diffracted to 1.995 Å and belong to space group P6 5 (Supplementary Table 1 and Supplementary Fig. 7) . The structure was solved by molecular replacement using the mEAG1 CNBHD (PDB accession 4F8A) as the search model. The final model was refined to a resolution of 1.995 Å with R work 5 0.167 and R free 5 0.197. Electrophysiology recordings were performed using the insideout configuration of the patch-clamp technique on Xenopus oocytes expressing wild-type and mutant channels as described previously 11 .
Full Methods and any associated references are available in the online version of the paper. 
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